For years, doctors have been warning of a post-antibiotic age with resistant mutations leading to so-called superbugs — multidrug-resistant infections that can evade the medicines designed to kill them. Faith Lapidus reports that the race is on to develop new drugs to treat these emerging, mutating infections.
Originally published at - [ Ссылка ]
